期刊文献+

氯诺昔康复合芬太尼对冠心病患者术后心肌缺血和血小板功能的影响

Effects of lornoxicam combined with fentanyl on postoperative myocardial ischemia and platelet function in patients with coronary heart disease
原文传递
导出
摘要 目的探讨氯诺昔康复合芬太尼对冠心病患者术后心肌缺血和血小板膜糖蛋白表达的影响。方法择期妇科手术患者100例,均有冠心病诊断,随机均分为两组,采用相同麻醉诱导及维持用药。术中及术后A组用氯诺昔康复合芬太尼镇痛,B组用芬太尼镇痛。记录术后VAS疼痛评分,监测术后1-8d动态心电图S-T改变,检测血小板计数(Plt)、凝血酶原时间(PT)、凝血酶时间(TT)、部分凝血酶时间(APTT)及血小板表面CD41/CD61、CD62P、CD63的表达量。结果两组术后4、12、24、48hVAS疼痛评分均<3分。A组术后第8天心肌缺血发生率明显比B组少(P<0.05),且A组血小板膜上的CD41/CD61、CD62P、CD63表达量明显低于B组(P<0.05)。结论氯诺昔康复合芬太尼镇痛可有效降低冠心病患者术后心肌缺血发生率,可能与其抑制血小板活化有关。 Objective To investigate the effects of lornoxicam combined with fentanyl on postoperative myocardial ischemia and platelet function in patients with coronary artery disease (CHD). Methods One hundred CHD patients undergoing selective gynecologic surgery were equally randomized into two groups of A (given lornoxicam combined with fentanyl for postoperative analgesia) and B(given fentanyl only). The VAS pain score was assessed in 48 hours after surgery. The changes of S-T segment were detected by Holter monitor in 1 to 8 days after operation. Blood samples were taken for the examinations of CD62p,CD63 and CD41/CD61 on the platelet membrance suface, platelet counts(Pit),thrombin proenzyme time(PT), thrombin time(TT), and part thrombin time(APTT). Results VAS scores of two groups were all less than 3 points during postoperative analgesia. The incidence of myocardial ischemia in group A was significantly lower in group A than that in group B on the 8th day after operation(P^0. 05) ,and the expressions of CD41/CD61 ,CD62p, CD63 in group A were significantly lower than those in group B as well(P^0. 05 or 0. 01). Conclusion Lornoxicam combined with fentanyl therapy can effectively reduce the incidence of postoperative myocardial iischemia in CHD patients undergoing gynecologic surgery, which may be through an inhibitory effect on the activation of platelet.
出处 《江苏医药》 CAS CSCD 北大核心 2012年第19期2263-2266,共4页 Jiangsu Medical Journal
关键词 氯诺昔康 芬太尼 冠心病 血小板膜糖蛋白 Lomoxicarn~ Fentanyl Coronary heart diseas Platelet membrane glycoproteins
  • 相关文献

参考文献10

  • 1Baron "JF, Bertrand M, Barre E, et al. Combined epidural and general anesthesia versus general anesthesia for abdominal aortic surgery[J]. Anesthesiology, 1991,75 (4) : 611-618.
  • 2Kullich W, Klein G. Influence of the nonsteroidal anti- inflammatory drug lornoxicam on the secretion of the endogenous opiate peptides dynorphin and 13-endorphin[J].Aktuel Rheumatol,1992,17(4)128-132.
  • 3Blaicher AM, Landsteiner HT, AL-Falaki O, et al. Acetylsalicy|ic acid, diclofenac, and lornoxicam, but not rofecoxib, affect platelet CD 62 expression[J]. Anesth Analg, 2004,98(4) : 1082-1085.
  • 4Blaicher AM, Landsteiner HT, Zwerina J, et al. Effect of non- selective, non-steroidal anti-inflammatory drugs and cyclo- oxygenase-2 selective inhibitors on the PFA-100 closure time [J]. Anaesthesia, 2004,59 (11) : 1100-1103.
  • 5Allen LaPointe NM, Kramer JM, DeLong ER. Patient- reported frequency of taking aspirin in a population with coronary artery disease[J]. Am J Cardiol, 2002,89 (9):1042 1046.
  • 6Altman R, Scazziota A. Role of anti-inflammatory drugs in the treatment of acute coronary syndromes, from athero- inflammation to athero-thrombosis [J]. Rev Esp Cardiol, 2003,56(1) :9-15.
  • 7Beatti WS, Buekley DN, Forrest JB. Epidural morphine reduces the risk of postoperative myocardial isehemia in patients with cardiac risk faetors[J]. Can J Anaesth, 1993,40 (6):532-541.
  • 8Deng MC, Daseh B, Erren M, et al. Impact of left ventricular dysfunction on cytokine, hemodynamies and outcome in bypass grafting[J]. Ann Thorae Surg,1996,62(1) : 184-190.
  • 9Shattil SJ, Cunnigham M, Hoxie Ja. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry[J]. Blood, 1987,70 (1):307-315.
  • 10陈东生,王宏梗.氯诺昔康复合小剂量芬太尼用于术后静脉镇痛[J].临床麻醉学杂志,2004,20(8):486-487. 被引量:18

二级参考文献8

  • 1刘肖平.非甾体抗炎药与术后多模式互补镇痛[J].国外医学(麻醉学与复苏分册),1996,17(4):193-195. 被引量:38
  • 2Pruss TP,Stroissnig H,Radhofer-Welte S, et al. Overview of the pharmacological properties, pharmacokinetics and animal safety assessment of lornoxicam. Postgrad Med J,1990,66(Suppl 4) :S18-21.
  • 3Olkkola KT,Brunetto AV, Mattila MJ. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents. Clin pharmacokinet, 1994,26:107-120.
  • 4Hitzenberger G,Radhofer-Welte S, Takacs F, et al. Pharmacokinetics of lornoxicam in man. Postgrad Med J,1990,66(Suppl 4) :S22-27.
  • 5Kullich W,Klein G. Influence of the nonsteroidal anti-inflammatory drug lornoxicam iv on the secretion of the endogenous opiate peptides dynorphin and endorphin. Aktuel Rheumatol, 1992,17:128-132.
  • 6Norholt SE,Sindet-Pedersen S,Larsen U,et al. Pain control after dental surgery: a double-blind, randomised trial of lornoxicam versus morphine. Pain, 1996,67: 335-343.
  • 7刘俊杰,赵俊,主编.现代麻醉学.北京:人民卫生出版社,1997.328.
  • 8郑恒兴,张英民,巩固,李杰,劳宁,熊利泽.小剂量氯胺酮复合芬太尼术后静脉镇痛[J].临床麻醉学杂志,2002,18(8):419-421. 被引量:42

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部